543 related articles for article (PubMed ID: 22747535)
1. Non-analgesic effects of opioids: opioid-induced respiratory depression.
Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
[TBL] [Abstract][Full Text] [Related]
2. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
Dahan A; Aarts L; Smith TW
Anesthesiology; 2010 Jan; 112(1):226-38. PubMed ID: 20010421
[TBL] [Abstract][Full Text] [Related]
4. Glial TLR4 signaling does not contribute to opioid-induced depression of respiration.
Zwicker JD; Zhang Y; Ren J; Hutchinson MR; Rice KC; Watkins LR; Greer JJ; Funk GD
J Appl Physiol (1985); 2014 Oct; 117(8):857-68. PubMed ID: 25103966
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
6. Naloxone reversal of buprenorphine-induced respiratory depression.
van Dorp E; Yassen A; Sarton E; Romberg R; Olofsen E; Teppema L; Danhof M; Dahan A
Anesthesiology; 2006 Jul; 105(1):51-7. PubMed ID: 16809994
[TBL] [Abstract][Full Text] [Related]
7. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
8. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
Lewanowitsch T; Irvine RJ
Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl depression of respiration: Comparison with heroin and morphine.
Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
[TBL] [Abstract][Full Text] [Related]
10. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
Elder HJ; Walentiny DM; Beardsley PM
Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
[TBL] [Abstract][Full Text] [Related]
11. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
van Lemmen M; Florian J; Li Z; van Velzen M; van Dorp E; Niesters M; Sarton E; Olofsen E; van der Schrier R; Strauss DG; Dahan A
Anesthesiology; 2023 Sep; 139(3):342-353. PubMed ID: 37402248
[TBL] [Abstract][Full Text] [Related]
12. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
[TBL] [Abstract][Full Text] [Related]
13. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
14. Differential impact of two critical respiratory centres in opioid-induced respiratory depression in awake mice.
Varga AG; Reid BT; Kieffer BL; Levitt ES
J Physiol; 2020 Jan; 598(1):189-205. PubMed ID: 31589332
[TBL] [Abstract][Full Text] [Related]
15. Activation of μ-opioid receptors differentially affects the preBötzinger Complex and neighbouring regions of the respiratory network in the adult rabbit.
Cinelli E; Bongianni F; Pantaleo T; Mutolo D
Respir Physiol Neurobiol; 2020 Sep; 280():103482. PubMed ID: 32553889
[TBL] [Abstract][Full Text] [Related]
16. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
[TBL] [Abstract][Full Text] [Related]
17. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
18. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity.
van der Schrier R; Dahan JDC; Boon M; Sarton E; van Velzen M; Niesters M; Dahan A
Anesthesiology; 2022 Apr; 136(4):618-632. PubMed ID: 34958670
[TBL] [Abstract][Full Text] [Related]
19. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
Kuo A; Wyse BD; Meutermans W; Smith MT
Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo.
Hajiha M; DuBord MA; Liu H; Horner RL
J Physiol; 2009 Jun; 587(Pt 11):2677-92. PubMed ID: 19403616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
